Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
32.42
-0.14 (-0.43%)
Nov 20, 2024, 4:00 PM EST - Market closed
Immunocore Holdings Employees
Immunocore Holdings had 497 employees as of December 31, 2023. The number of employees increased by 89 or 21.81% compared to the previous year.
Employees
497
Change (1Y)
89
Growth (1Y)
21.81%
Revenue / Employee
$596,201
Profits / Employee
-$94,660
Market Cap
1.62B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Teladoc Health | 5,600 |
10x Genomics | 1,259 |
InMode | 581 |
Clover Health Investments | 552 |
Arvinas | 445 |
Dynavax Technologies | 408 |
Kiniksa Pharmaceuticals International, | 297 |
Nurix Therapeutics | 284 |
IMCR News
- 13 days ago - Immunocore to present at upcoming investor conferences - GlobeNewsWire
- 15 days ago - Immunocore reports third quarter financial results and provides a business update - GlobeNewsWire
- 2 months ago - Immunocore presents Phase 1 data of brenetafusp, an ImmTAC bispecific targeting PRAME, in patients with ovarian cancer - GlobeNewsWire
- 2 months ago - Immunocore to present at the 2024 Cantor Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Immunocore: Pipeline Expands HLA Tumor Targeting Beyond Kimmtrak - Seeking Alpha
- 3 months ago - Immunocore Holdings: KIMMTRAK Success, Diverse Pipeline, And Potential Big Pharma Appeal - Seeking Alpha
- 3 months ago - Immunocore Holdings plc (IMCR) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response - GlobeNewsWire